Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypofractionated Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01219790
What this trial is testing

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
Institut Cancerologie de l'Ouest 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03693014
What this trial is testing

Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Who this might be right for
Metastatic CancerMelanoma CancerLung Cancer+3 more
Memorial Sloan Kettering Cancer Center 69
Early research (Phase 1)WithdrawnNCT02080949
What this trial is testing

Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases

Who this might be right for
Brain Metastases
Barretos Cancer Hospital
Not applicableNot Yet RecruitingNCT05614700
What this trial is testing

Prostate Reirradiation Toxicity Outcomes Feasibility Study

Who this might be right for
Prostate CancerRadiotherapy Side Effect
University of Leeds 60
Not applicableUnknownNCT05364411
What this trial is testing

HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypofractionationRadiotherapy+2 more
Joris B.W. Elbers 100
Not applicableStudy completedNCT07489729
What this trial is testing

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

Who this might be right for
Hypofractionated DoseProstate Cancer Patients
Tanta University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04997018
What this trial is testing

MRI-guided High-dose Radiation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 91
Not applicableStudy completedNCT01705548
What this trial is testing

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

Who this might be right for
Metastatic Malignant Neoplasm to BrainUnspecified Adult Solid Tumor, Protocol Specific
Emory University 24
Testing effectiveness (Phase 2)Looking for participantsNCT07173972
What this trial is testing

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma (STS)Soft Tissue Sarcoma AdultSoft Tissue Sarcoma of the Trunk and Extremities+7 more
Oslo University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01497808
What this trial is testing

RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA

Who this might be right for
Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)Study completedNCT02004418
What this trial is testing

Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland

Who this might be right for
Prostatic Neoplasms
AHS Cancer Control Alberta 21
Not applicableEnded earlyNCT01488968
What this trial is testing

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients

Who this might be right for
High-risk Prostate Cancer
AHS Cancer Control Alberta 111
Not applicableLooking for participantsNCT03920033
What this trial is testing

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

Who this might be right for
Prostate CancerBiochemical RecurrenceRadiation+5 more
Asan Medical Center 288
Early research (Phase 1)Study completedNCT04951063
What this trial is testing

Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC

Who this might be right for
Locally Advanced Lung Carcinoma
Sun Yat-sen University 18
Large-scale testing (Phase 3)Active Not RecruitingNCT02303327
What this trial is testing

Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 307
Early research (Phase 1)Active Not RecruitingNCT04486755
What this trial is testing

Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Maryland, Baltimore 18
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)UnknownNCT05451173
What this trial is testing

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Who this might be right for
Non-small Cell Lung CancerNon-small Cell CarcinomaNon-small Cell Lung Cancer Stage I+2 more
Alexander Chi 83
Testing effectiveness (Phase 2)Study completedNCT00907569
What this trial is testing

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmSmall Cell Carcinoma
AHS Cancer Control Alberta 2
Not applicableStudy completedNCT00243841
What this trial is testing

Dose Escalation Study for Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Indiana University 77
Next Page